Oportun Financial (NASDAQ:OPRT) Stock, Quote.Headers.trade-ideas

Oportun Financial

Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.

Stock Market

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ABEO

HIBB

JBLU

OPRT

PALI

Crude Oil Moves Higher; General Motors Earnings Top Views

Movers

AZTR

CALX

CDTX

CHCI

CSLR

CTCX

FCEL

GWAV

HRTX

HSTM

JAGX

KULR

LICN

MESO

MLEC

MSCI

PEGY

PHIO

RNAC

ROKU

SMFL

SMXT

SPCB

SPCE

SPOT

TIRX

TRSG

TTOO

YYGH

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Dow Jumps Over 200 Points; US Services PMI Falls In April

Oportun Financial Corporation - common stock

Oportun Financial Corp

Morgan Stanley analyst Michael Cyprys maintains TPG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with a Overweight and raises the price target from $55 to $73.

Price Target

Analyst Ratings

Morgan Stanley Maintains Overweight on TPG, Raises Price Target to $73

- Reuters Citing Excerpt From Upcoming Detroit Speech

Macro Economic Events

Politics

Global

Economics

General

Trump Says He Will Bar All Chinese Autonomous Vehicles From Traveling On U.S. Roads

<a href="https://www.youtube.com/watch?v=vJ8aEO6ggOs" title="https://www.youtube.com/watch?v=vJ8aEO6ggOs">https://www.youtube.com/watch?v=vJ8aEO6ggOs</a>

Guidance

AMD Exec Says Plans To Make Next Generation MI350 Series AI Chips Available In The Second Half Of 2025

Morgan Stanley analyst Michael Cyprys maintains StepStone Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STEP#NASDAQ">STEP</a>) with a Equal-Weight and raises the price target from $52 to $60.

STEP

Morgan Stanley Maintains Equal-Weight on StepStone Group, Raises Price Target to $60

Trump To Propose Making Interest On Car Loans Fully Tax-Deductible; To Propose A 'Made In America' Corporate Tax Rate Of 15% For U.S. Manufacturers

Morgan Stanley analyst Michael Cyprys maintains P10 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PX#NYSE">PX</a>) with a Equal-Weight and raises the price target from $10 to $12.

Morgan Stanley Maintains Equal-Weight on P10, Raises Price Target to $12

As the cannabis industry faces significant headwinds in 2024, two companies — Dutchie and C3 Industries — are bucking the trend. During the <a href="https://www.benzinga.com/events/cannabis-conference/">Benzinga Cannabis Capital Conference</a>, CEOs Tim Barash and Ankur Rungta, respectively, shared insights on Oct. 9 at a fireside discussion into how they are achieving impressive growth despite a challenging market environment. The moderator was Jay Rosenthal.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can't afford to miss out if you&#8217;re serious about the business.</li>
</ul>
<h1 class="wp-block-heading">Dutchie's 80% Growth: Smarter, Focused Expansion</h1>
Amid a climate where many cannabis companies are struggling, Dutchie is set to grow by 80% in 2024. CEO Barash attributes this success to a strategic, measured approach: &#8220;When the cost of capital rises, long-term thinking has to be more balanced. It's not about conquering the world, but about smart, focused growth.&#8221;
Dutchie's key move? The launch of Dutchie 2.0, which brings an Amazon-like experience to cannabis retailers. The platform focuses on enhancing customer service, simplifying transactions and improving operational efficiency. By offering tech-driven solutions, Dutchie is helping its partners optimize their retail operations, a crucial factor in their explosive growth despite industry-wide challenges.
Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/10/41262813/exclusive-poking-the-bear-as-floridas-contentious-cannabis-legalization-vote-looms"> EXCLUSIVE: &#8216;Poking The Bear&#8217; As Florida&#8217;s Contentious Cannabis Legalization Vote Looms</a>
<h1 class="wp-block-heading">C3 Industries: Data-Driven Optimization</h1>
C3 CEO Rungta emphasized the power of data in navigating the volatile cannabis market. With mature markets such as Michigan plateauing or even contracting, C3 has shifted focus to increasing same-store sales and profitability. 
"Mature recreational markets have stalled or contracted, so we must look inward and make our businesses better from the inside out," Rungta explained.
C3 Industries is optimizing every part of its operations using technology and data. From improving back-end processes to enhancing the customer experience, C3 is positioning itself for continued growth even in a shrinking market. "It's about block and tackle — the fundamentals of retail,&#8221; Rungta said.
<h1 class="wp-block-heading">Adapting To Market Headwinds</h1>
Both CEOs acknowledged the broader challenges in the cannabis market, from regulatory hurdles to pricing pressures. Barash pointed out that price compression has been a persistent issue, with cultivators struggling to stay afloat. However, their companies are navigating these challenges by honing in on efficiency and avoiding overextension.
"We&#8217;re not expecting miracles from federal reform," Barash noted. "But if you focus on what you can control — your team, your resources, and your technology — you can still win."
<h1 class="wp-block-heading">Lessons For Cannabis Investors</h1>
The growth of Dutchie and C3 Industries in such a difficult market offers valuable lessons for cannabis investors. By focusing on technology, operational efficiency and strategic investments, both companies are thriving despite the broader market&#8217;s struggles. Investors looking for resilient cannabis businesses should take note: success in 2024 hinges on growing smarter, not harder.
Read Next: • <a href="https://www.benzinga.com/markets/cannabis/24/10/41262320/jim-belushi-compares-passion-for-acting-to-cannabis-business-makes-people-feel-good">Jim Belushi Compares Passion For Acting To Cannabis Business: &#8216;Makes People Feel Good&#8217;</a>
Photo: Benzinga Cannabis Capital Conference, Oct. 9, 2024, photo by Wendy Davis

Cannabis

Retail Sales

Events

Exclusives

Tech

Interview

EXCLUSIVE: 80% Growth Despite The Chaos: How Dutchie, C3 Defy 2024's Cannabis Slump

Morgan Stanley analyst Michael Cyprys maintains KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) with a Equal-Weight and raises the price target from $107 to $143.

Morgan Stanley Maintains Equal-Weight on KKR, Raises Price Target to $143

Morgan Stanley analyst Michael Cyprys maintains Hamilton Lane (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) with a Equal-Weight and raises the price target from $140 to $182.

HLNE

Morgan Stanley Maintains Equal-Weight on Hamilton Lane, Raises Price Target to $182

Management

Citigroup Establishes Banking Executive Team

Morgan Stanley analyst Michael Cyprys maintains Carlyle Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CG#NASDAQ">CG</a>) with a Equal-Weight and raises the price target from $46 to $50.

Morgan Stanley Maintains Equal-Weight on Carlyle Group, Raises Price Target to $50

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) with a Buy and maintains $37 price target.

Reiteration

PHAR

HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target

Morgan Stanley analyst Michael Cyprys maintains Bridge Investment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRDG#NYSE">BRDG</a>) with a Overweight and raises the price target from $11 to $14.

BRDG

Morgan Stanley Maintains Overweight on Bridge Investment Group, Raises Price Target to $14

Morgan Stanley analyst Michael Cyprys maintains Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) with a Overweight and raises the price target from $164 to $177.

Morgan Stanley Maintains Overweight on Blackstone, Raises Price Target to $177

<h3>Gainers</h3>
<ul>
<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares increased by 62.2% to $1.16 during Thursday's regular session. The market value of their outstanding shares is at $15.5 million. </li>
<li>Trump Media &amp; Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) stock rose 14.97% to $23.65. The company's market cap stands at $4.7 billion. </li>
<li>Sify Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) shares rose 12.79% to $2.91. The company's market cap stands at $1.2 billion. </li>
<li>CuriosityStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURI#NASDAQ">CURI</a>) shares rose 11.22% to $2.08. The market value of their outstanding shares is at $113.5 million. </li>
<li>Fangdd Network Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUO#NASDAQ">DUO</a>) stock moved upwards by 8.23% to $1.91. The company's market cap stands at $15.3 million. </li>
<li>Antelope Ent Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) shares rose 8.18% to $0.7. The company's market cap stands at $8.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>9F (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFU#NASDAQ">JFU</a>) shares declined by 16.6% to $1.81 during Thursday's regular session. The company's market cap stands at $21.3 million. </li>
<li>36KR Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRKR#NASDAQ">KRKR</a>) shares fell 11.54% to $4.68. The company's market cap stands at $182.5 million. </li>
<li>Reading Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDIB#NASDAQ">RDIB</a>) stock decreased by 9.99% to $6.67. The market value of their outstanding shares is at $149.5 million. </li>
<li>MultiMetaVerse Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMV#NASDAQ">MMV</a>) stock decreased by 7.45% to $0.46. The company's market cap stands at $15.2 million. </li>
<li>LiveOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVO#NASDAQ">LVO</a>) stock fell 7.25% to $0.69. The market value of their outstanding shares is at $68.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEHL

BLMZ

CURI

KRKR

Eaton Vance Massachusetts Municipal Income Trust

RDIB

SIFY

11 Communication Services Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) stock rose 20.0% to $0.65 during Thursday's regular session. The market value of their outstanding shares is at $11.2 million. </li>
<li>Vaccinex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCNX#NASDAQ">VCNX</a>) shares increased by 18.88% to $2.14. The company's market cap stands at $5.5 million. </li>
<li>NexGel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXGL#NASDAQ">NXGL</a>) stock increased by 17.65% to $2.82. The market value of their outstanding shares is at $17.8 million. </li>
<li>Cue Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUE#NASDAQ">CUE</a>) stock rose 17.01% to $1.41. The company's market cap stands at $84.8 million. </li>
<li>Genenta Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNTA#NASDAQ">GNTA</a>) shares increased by 15.81% to $6.5. The company's market cap stands at $118.4 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares moved upwards by 13.69% to $5.98. The company's market cap stands at $77.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Gritstone Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTS#NASDAQ">GRTS</a>) stock declined by 64.2% to $0.07 during Thursday's regular session. The market value of their outstanding shares is at $8.3 million. </li>
<li>10x Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) stock fell 25.21% to $15.57. The company's market cap stands at $1.8 billion. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares fell 21.17% to $0.4. The market value of their outstanding shares is at $2.2 million. </li>
<li>ADMA Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) stock declined by 19.46% to $16.37. The market value of their outstanding shares is at $3.8 billion. </li>
<li>Tempest Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) shares decreased by 17.78% to $1.11. The company's market cap stands at $27.9 million. </li>
<li>Indivior (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDV#NASDAQ">INDV</a>) stock fell 17.27% to $7.81. The company's market cap stands at $1.0 billion. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADMA

GNTA

GRTS

HCTI

INDV

NXGL

RNAZ

Tempest Therapeutics, Inc. - Common Stock

TPST

VCNX

12 Health Care Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Jet AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) shares moved upwards by 95.5% to $0.18 during Thursday's regular session. The market value of their outstanding shares is at $4.4 million. </li>
<li>Galaxy Payroll Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXG#NASDAQ">GLXG</a>) shares moved upwards by 32.46% to $10.2. The market value of their outstanding shares is at $181.0 million. </li>
<li>Surf Air Mobility (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) shares rose 31.36% to $3.06. The market value of their outstanding shares is at $39.2 million. </li>
<li>GXO Logistics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GXO#NYSE">GXO</a>) shares moved upwards by 14.48% to $58.27. The company's market cap stands at $6.9 billion. </li>
<li>Symbotic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares increased by 14.18% to $26.54. The company's market cap stands at $2.7 billion. </li>
<li>Turbo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TURB#NASDAQ">TURB</a>) stock moved upwards by 13.47% to $2.87. The market value of their outstanding shares is at $31.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Momentus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) shares fell 26.8% to $0.78 during Thursday's regular session. The market value of their outstanding shares is at $19.8 million. </li>
<li>JVSPAC Acquisition Corp. - Right (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSAR#NASDAQ">JVSAR</a>) stock declined by 16.97% to $0.27. </li>
<li>Nature's Miracle Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) shares declined by 12.59% to $0.17. The company's market cap stands at $5.3 million. </li>
<li>Graphex Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GRFX#AMEX">GRFX</a>) shares decreased by 8.68% to $0.23. The market value of their outstanding shares is at $11.1 million. </li>
<li>Laser Photonics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASE#NASDAQ">LASE</a>) shares declined by 8.46% to $8.01. The market value of their outstanding shares is at $122.3 million. </li>
<li>Simpple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) shares decreased by 7.99% to $0.43. The market value of their outstanding shares is at $6.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GLXG

GRFX

JTAI

JVSAR

LASE

MNTS

NMHI

SPPL

SRFM

TURB

12 Industrials Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares moved upwards by 41.9% to $0.36 during Thursday's regular session. The company's market cap stands at $2.7 million. </li>
<li>MultiSensor AI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSAI#NASDAQ">MSAI</a>) stock increased by 11.96% to $1.88. The company's market cap stands at $44.8 million. </li>
<li>Akoustis Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTS#NASDAQ">AKTS</a>) stock increased by 10.8% to $0.08. The market value of their outstanding shares is at $8.7 million. </li>
<li>Phunware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) stock moved upwards by 10.7% to $3.93. The market value of their outstanding shares is at $44.5 million. </li>
<li>Lightwave Logic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWLG#NASDAQ">LWLG</a>) stock increased by 10.37% to $2.98. The company's market cap stands at $359.7 million. </li>
<li>Atomera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) stock increased by 10.21% to $3.56. The market value of their outstanding shares is at $98.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) stock declined by 25.8% to $0.53 during Thursday's regular session. </li>
<li>E2open Parent Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) stock declined by 18.88% to $3.31. The company's market cap stands at $1.0 billion. As per the news, the Q2 earnings report came out yesterday. </li>
<li>XIAO-I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) stock decreased by 14.82% to $5.52. The market value of their outstanding shares is at $402.8 million. </li>
<li>NiSun Intl Enterprise Dev (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NISN#NASDAQ">NISN</a>) shares declined by 12.23% to $12.49. The company's market cap stands at $49.3 million. </li>
<li>Wetouch Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETH#NASDAQ">WETH</a>) stock declined by 11.43% to $1.86. The market value of their outstanding shares is at $22.1 million. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) stock declined by 11.35% to $0.78. The market value of their outstanding shares is at $76.5 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIXI

AKTS

ATOM

CETX

ETWO

LWLG

MLGO

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

NISN

PHUN

WETH

12 Information Technology Stocks Moving In Thursday's Intraday Session

Morgan Stanley analyst Michael Cyprys maintains Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) with a Equal-Weight and raises the price target from $136 to $162.

ARES

Morgan Stanley Maintains Equal-Weight on Ares Management, Raises Price Target to $162

AMD Executive Launches New MI325X AI Chip, Shipping From Partners In Q1 2025

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Oportun Financial (NASDAQ:<a href="https://investorplace.com/stock-quotes/oprt-stock-quote/">OPRT</a>) just reported results for the second quarter of 2024.<ul><li>Oportun Financial reported earnings per share of 8 cents. This was above the analyst estimate for EPS of -15 cents.</li><li>The company reported revenue of $250.40 million.</li><li>This was 1.77% better than the analyst estimate for revenue of $246.05 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/oprt-stock-earnings-oportun-financial-for-q2-of-2024/">OPRT Stock Earnings: Oportun Financial Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OPRT Stock Earnings: Oportun Financial Beats EPS, Beats Revenue for Q2 2024

Oportun Financial GAAP EPS of -$0.78, revenue of $250M

Oportun Financial Corporation 2024 Q2 - Results - Earnings Call Presentation

Oportun Financial Corporation (OPRT) Q2 2024 Earnings Call Transcript

In a report released today, David Scharf from JMP Securities maintained a Hold rating on Oportun Financial (OPRT – Research Report). The company's ...

Oportun Financial (OPRT) Receives a Hold from JMP Securities

Warning: OPRT is at high risk of performing badly

Oportun gets $306M committed warehouse facility extension

Oportun to sell credit card portfolio

Oportun Financial ( ($OPRT) ) has issued an announcement. Oportun Financial Corporation has enhanced its lending capabilities with a Master Amendme...

Oportun Financial Expands Lending and Sells Credit Portfolio

Jefferies analyst John Hecht maintained a Hold rating on Oportun Financial (OPRT – Research Report) today and set a price target of $3.50. The comp...

Oportun Financial (OPRT) Gets a Hold from Jefferies

Press Releases

Oportun to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Oportun Announces $245 Million Committed Warehouse Facility

Earnings

Oportun Reports Second Quarter 2024 Financial Results

Concerned Shareholders of Oportun Financial Corporation Reiterate Call for Nominating, Governance and Social Responsibility Committee Chair Ginny Lee to Resign

Oportun Named a Bay Area Top Workplace for 2024

Oportun Completes $223 Million Asset Backed Securitization

Oportun to Present at Sidoti September Virtual Investor Conference

Singular Research Initiates Coverage on Oportun Financial Corp (OPRT) with a Buy Rating and a $5.50 Price Target

Oportun Announces $306 Million Committed Warehouse Facility Extension

Financing

Oportun Announces Definitive Agreement to Sell its Credit Card Portfolio

Senmiao Technology Limited - Common Stock

Senmiao Tech

Atlanticus Holdings Corporation - Common Stock

Atlanticus Holdings

Consumer Portfolio Services, Inc. - Common Stock

Consumer Pf Servs

Green Dot Corporation Class A Common Stock, $0.001 par value

Green Dot

Jiayin Group Inc. - American Depositary Shares

Jiayin Gr

Janover

Katapult Holdings

LexinFintech Holdings Ltd. - American Depositary Shares

LexinFintech Holdings

Metalpha Technology Holding Limited - Ordinary Shares

Metalpha Technology

Medallion Finl

MoneyLion

Old Market Capital Corporation - Common Stock

Old Market Capital

OppFi

Pintec Technology Holdings Limited - American Depositary Shares

Pintec Technology Hldgs

Qudian Inc. American Depositary Shares, each representing one Class A Ordinary Share

Qudian

Regional Mgmt

X Financial American Depositary Shares, each representing six Class A Ordinary Shares

X Financial

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Oportun Financial

Oportun Financial (OPRT) Forecast

Oportun Financial (NASDAQ:OPRT) Stock, Quote.Headers.trade-ideas